Loading…

Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide

[Display omitted] Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum ha...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2019-06, Vol.564, p.171-179
Main Authors: Brammann, Christoph, Mueller-Goymann, Christel C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033
cites cdi_FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033
container_end_page 179
container_issue
container_start_page 171
container_title International journal of pharmaceutics
container_volume 564
creator Brammann, Christoph
Mueller-Goymann, Christel C.
description [Display omitted] Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum has been shown. By embedding nanoparticulate benzoyl peroxide in lipid microparticles, the therapeutic potency of adapalene can be further increased by improving follicular deposition of benzoyl peroxide and minimizing direct contact between benzoyl peroxide and stratum corneum, which is responsible for the irritating potential of this active agent. The aim of this study was to develop a novel nanoparticulate formulation for benzoyl peroxide suitable for the incorporation in solid lipid microparticles. In this contribution, a wet grinding process using liposomal dispersions of fully hydrated phosphatidylcholine was developed, upscaled and optimized for solid content and stabilizer concentration. The resulting novel nanosuspension was characterized by particle size and morphology and examined for chemical and physical stability as well as solubility and polymorphism. During the process development a dependency between the colloidal microstructure of the stabilizer dispersion and milling efficiency was found: while physical mixtures fail to deliver nanosuspensions, liposomal dispersions succeed with the same amount of stabilizer.
doi_str_mv 10.1016/j.ijpharm.2019.04.031
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2211945122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517319302935</els_id><sourcerecordid>2211945122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033</originalsourceid><addsrcrecordid>eNqFUcuO1DAQtBCIHRY-AeQjl4R2_MiEC0IrHiOtgAOcLcfuCI8cO9gZxHDiA7jxh3wJXs0ABw6opa4-VFepuwh5yKBlwNSTfev3y0eT57YDNrQgWuDsFtmwbc8bLnp1m2yA99tGsp5fkHul7AFAdYzfJRcchmEAyTbk-y7alJeUzepTpGmiI8av6Rjogjl98Q5pNDHZfCyrCYX6uCZqnFlMwIhNSMahoyUF72jwS-2ztzktJq_eBixP6bs60h39-e0HffNXKfiI_1jdJ3emaoIPznhJPrx88f7qdXP99tXu6vl1Y7mSa8OkE6iUsUKMteTQo8KOGztOE5cKDAe3HXs1ODWOHEQ3bgX0qu9lRQacX5LHJ90lp08HLKuefbEYgomYDkV3HWODkKzrKlWeqPWoUjJOesl-NvmoGeibIPRen4PQN0FoELoGUfcenS0O44zuz9bvz1fCsxMB66GfPWZdrMdo0fmMdtUu-f9Y_AJ-iqAz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2211945122</pqid></control><display><type>article</type><title>Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Brammann, Christoph ; Mueller-Goymann, Christel C.</creator><creatorcontrib>Brammann, Christoph ; Mueller-Goymann, Christel C.</creatorcontrib><description>[Display omitted] Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum has been shown. By embedding nanoparticulate benzoyl peroxide in lipid microparticles, the therapeutic potency of adapalene can be further increased by improving follicular deposition of benzoyl peroxide and minimizing direct contact between benzoyl peroxide and stratum corneum, which is responsible for the irritating potential of this active agent. The aim of this study was to develop a novel nanoparticulate formulation for benzoyl peroxide suitable for the incorporation in solid lipid microparticles. In this contribution, a wet grinding process using liposomal dispersions of fully hydrated phosphatidylcholine was developed, upscaled and optimized for solid content and stabilizer concentration. The resulting novel nanosuspension was characterized by particle size and morphology and examined for chemical and physical stability as well as solubility and polymorphism. During the process development a dependency between the colloidal microstructure of the stabilizer dispersion and milling efficiency was found: while physical mixtures fail to deliver nanosuspensions, liposomal dispersions succeed with the same amount of stabilizer.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2019.04.031</identifier><identifier>PMID: 30999051</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Benzoyl peroxide ; Fully hydrated phosphatidylcholine ; Nanosuspension ; Wet media milling</subject><ispartof>International journal of pharmaceutics, 2019-06, Vol.564, p.171-179</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033</citedby><cites>FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033</cites><orcidid>0000-0002-3561-4737</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30999051$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brammann, Christoph</creatorcontrib><creatorcontrib>Mueller-Goymann, Christel C.</creatorcontrib><title>Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum has been shown. By embedding nanoparticulate benzoyl peroxide in lipid microparticles, the therapeutic potency of adapalene can be further increased by improving follicular deposition of benzoyl peroxide and minimizing direct contact between benzoyl peroxide and stratum corneum, which is responsible for the irritating potential of this active agent. The aim of this study was to develop a novel nanoparticulate formulation for benzoyl peroxide suitable for the incorporation in solid lipid microparticles. In this contribution, a wet grinding process using liposomal dispersions of fully hydrated phosphatidylcholine was developed, upscaled and optimized for solid content and stabilizer concentration. The resulting novel nanosuspension was characterized by particle size and morphology and examined for chemical and physical stability as well as solubility and polymorphism. During the process development a dependency between the colloidal microstructure of the stabilizer dispersion and milling efficiency was found: while physical mixtures fail to deliver nanosuspensions, liposomal dispersions succeed with the same amount of stabilizer.</description><subject>Benzoyl peroxide</subject><subject>Fully hydrated phosphatidylcholine</subject><subject>Nanosuspension</subject><subject>Wet media milling</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFUcuO1DAQtBCIHRY-AeQjl4R2_MiEC0IrHiOtgAOcLcfuCI8cO9gZxHDiA7jxh3wJXs0ABw6opa4-VFepuwh5yKBlwNSTfev3y0eT57YDNrQgWuDsFtmwbc8bLnp1m2yA99tGsp5fkHul7AFAdYzfJRcchmEAyTbk-y7alJeUzepTpGmiI8av6Rjogjl98Q5pNDHZfCyrCYX6uCZqnFlMwIhNSMahoyUF72jwS-2ztzktJq_eBixP6bs60h39-e0HffNXKfiI_1jdJ3emaoIPznhJPrx88f7qdXP99tXu6vl1Y7mSa8OkE6iUsUKMteTQo8KOGztOE5cKDAe3HXs1ODWOHEQ3bgX0qu9lRQacX5LHJ90lp08HLKuefbEYgomYDkV3HWODkKzrKlWeqPWoUjJOesl-NvmoGeibIPRen4PQN0FoELoGUfcenS0O44zuz9bvz1fCsxMB66GfPWZdrMdo0fmMdtUu-f9Y_AJ-iqAz</recordid><startdate>20190610</startdate><enddate>20190610</enddate><creator>Brammann, Christoph</creator><creator>Mueller-Goymann, Christel C.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3561-4737</orcidid></search><sort><creationdate>20190610</creationdate><title>Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide</title><author>Brammann, Christoph ; Mueller-Goymann, Christel C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Benzoyl peroxide</topic><topic>Fully hydrated phosphatidylcholine</topic><topic>Nanosuspension</topic><topic>Wet media milling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brammann, Christoph</creatorcontrib><creatorcontrib>Mueller-Goymann, Christel C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brammann, Christoph</au><au>Mueller-Goymann, Christel C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2019-06-10</date><risdate>2019</risdate><volume>564</volume><spage>171</spage><epage>179</epage><pages>171-179</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum has been shown. By embedding nanoparticulate benzoyl peroxide in lipid microparticles, the therapeutic potency of adapalene can be further increased by improving follicular deposition of benzoyl peroxide and minimizing direct contact between benzoyl peroxide and stratum corneum, which is responsible for the irritating potential of this active agent. The aim of this study was to develop a novel nanoparticulate formulation for benzoyl peroxide suitable for the incorporation in solid lipid microparticles. In this contribution, a wet grinding process using liposomal dispersions of fully hydrated phosphatidylcholine was developed, upscaled and optimized for solid content and stabilizer concentration. The resulting novel nanosuspension was characterized by particle size and morphology and examined for chemical and physical stability as well as solubility and polymorphism. During the process development a dependency between the colloidal microstructure of the stabilizer dispersion and milling efficiency was found: while physical mixtures fail to deliver nanosuspensions, liposomal dispersions succeed with the same amount of stabilizer.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30999051</pmid><doi>10.1016/j.ijpharm.2019.04.031</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3561-4737</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2019-06, Vol.564, p.171-179
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2211945122
source ScienceDirect Freedom Collection 2022-2024
subjects Benzoyl peroxide
Fully hydrated phosphatidylcholine
Nanosuspension
Wet media milling
title Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: Part I – Nanocrystalline benzoyl peroxide
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A26%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incorporation%20of%20benzoyl%20peroxide%20nanocrystals%20into%20adapalene-loaded%20solid%20lipid%20microparticles:%20Part%20I%20%E2%80%93%20Nanocrystalline%20benzoyl%20peroxide&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Brammann,%20Christoph&rft.date=2019-06-10&rft.volume=564&rft.spage=171&rft.epage=179&rft.pages=171-179&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2019.04.031&rft_dat=%3Cproquest_cross%3E2211945122%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-15d4e66ac44b4b4597e6e23acbff3560a30d8b769d6bb3042b840767758401033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2211945122&rft_id=info:pmid/30999051&rfr_iscdi=true